Skip to main content
Erschienen in: Journal of General Internal Medicine 5/2020

10.12.2019 | Original Research

Translating CKD Research into Primary Care Practice: a Group-Randomized Study

verfasst von: Cara B. Litvin, MD, MS, Paul J. Nietert, PhD, Ruth G. Jenkins, PhD, Andrea M. Wessell, PharmD, Lynne S. Nemeth, PhD, RN, Steven M. Ornstein, MD

Erschienen in: Journal of General Internal Medicine | Ausgabe 5/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Chronic kidney disease (CKD) is common in the primary care setting. Early interventions may prevent progression of renal disease and reduce risk for cardiovascular complications, yet quality gaps have been documented. Successful approaches to improve identification and management of CKD in primary care are needed.

Objective

To assess whether implementation of a primary care improvement model results in improved identification and management of CKD

Design

18-month group-randomized study

Participants

21 primary care practices in 13 US states caring for 107,094 patients

Interventions

To promote implementation of CKD improvement strategies, intervention practices received clinical quality measure (CQM) reports at least quarterly, hosted an on-site visit and 2 webinars, and sent clinician/staff representatives to a “best practice” meeting. Control practices received CQM reports at least quarterly.

Main Measures

Changes in practice adherence to a set of 11 CKD CQMs

Key Results

We observed significantly greater improvements among intervention practices for annual screening for albuminuria in patients with diabetes or hypertension (absolute change 22% in the intervention group vs. − 2.6% in the control group, p < 0.0001) and annual monitoring for albuminuria in patients with CKD (absolute change 21% in the intervention group vs. − 2.0% in the control group, p < 0.0001). Avoidance of NSAIDs in patients with CKD declined in both intervention and control groups, with a significantly greater decline in the control practices (absolute change − 5.0% in the intervention group vs. − 10% in the control group, p < 0.0001). There were no other significant changes found for the other CQMs. Variable implementation of CKD improvement strategies was noted across the intervention practices.

Conclusions

Implementation of a primary care improvement model designed to improve CKD identification and management resulted in significantly improved care on 3 out of 11 CQMs. Incomplete adoption of improvement strategies may have limited further improvement. Improving CKD identification and management likely requires a longer and more intensive intervention.
Literatur
1.
Zurück zum Zitat Saran R, Li Y, Robinson B. US Renal Data System 2014 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis.66(1 (suppl 2)):S1-S306. Saran R, Li Y, Robinson B. US Renal Data System 2014 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis.66(1 (suppl 2)):S1-S306.
2.
Zurück zum Zitat Wouters OJ, O’Donoghue DJ, Ritchie J, Kanavos PG, Narva AS. Early chronic kidney disease: diagnosis, management and models of care. Nat Rev Nephrol 2015;11(8):491–502.PubMedPubMedCentral Wouters OJ, O’Donoghue DJ, Ritchie J, Kanavos PG, Narva AS. Early chronic kidney disease: diagnosis, management and models of care. Nat Rev Nephrol 2015;11(8):491–502.PubMedPubMedCentral
3.
Zurück zum Zitat Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296–1305.CrossRef Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296–1305.CrossRef
4.
Zurück zum Zitat Foster MC, Rawlings AM, Marrett E, et al. Cardiovascular risk factor burden, treatment, and control among adults with chronic kidney disease in the United States. Am Heart J 2013;166(1):150–156.PubMedPubMedCentral Foster MC, Rawlings AM, Marrett E, et al. Cardiovascular risk factor burden, treatment, and control among adults with chronic kidney disease in the United States. Am Heart J 2013;166(1):150–156.PubMedPubMedCentral
5.
Zurück zum Zitat Fox CH, Brooks A, Zayas LE, McClellan W, Murray B. Primary care physicians’ knowledge and practice patterns in the treatment of chronic kidney disease: an Upstate New York Practice-based Research Network (UNYNET) study. J Am Board Fam Med 2006;19(1):54–61.PubMed Fox CH, Brooks A, Zayas LE, McClellan W, Murray B. Primary care physicians’ knowledge and practice patterns in the treatment of chronic kidney disease: an Upstate New York Practice-based Research Network (UNYNET) study. J Am Board Fam Med 2006;19(1):54–61.PubMed
6.
Zurück zum Zitat Philipneri MD, Rocca Rey LA, Schnitzler MA, et al. Delivery patterns of recommended chronic kidney disease care in clinical practice: administrative claims-based analysis and systematic literature review. Clin Exp Nephrol 2008;12(1):41–52.PubMed Philipneri MD, Rocca Rey LA, Schnitzler MA, et al. Delivery patterns of recommended chronic kidney disease care in clinical practice: administrative claims-based analysis and systematic literature review. Clin Exp Nephrol 2008;12(1):41–52.PubMed
7.
Zurück zum Zitat Shahinian VB, Saran R. The role of primary care in the management of the chronic kidney disease population. Adv Chronic Kidney Dis 2010;17(3):246–253.PubMed Shahinian VB, Saran R. The role of primary care in the management of the chronic kidney disease population. Adv Chronic Kidney Dis 2010;17(3):246–253.PubMed
8.
Zurück zum Zitat Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet. 2013;382(9889):339–352.PubMed Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet. 2013;382(9889):339–352.PubMed
9.
Zurück zum Zitat de Jong PE, Curhan GC. Screening, monitoring, and treatment of albuminuria: Public health perspectives. J Am Soc Nephrol 2006;17(8):2120–2126.PubMed de Jong PE, Curhan GC. Screening, monitoring, and treatment of albuminuria: Public health perspectives. J Am Soc Nephrol 2006;17(8):2120–2126.PubMed
10.
Zurück zum Zitat Karalliedde J, Viberti G. Microalbuminuria and cardiovascular risk. Am J Hypertens 2004;17(10):986–993.PubMed Karalliedde J, Viberti G. Microalbuminuria and cardiovascular risk. Am J Hypertens 2004;17(10):986–993.PubMed
11.
Zurück zum Zitat Palmer SC, Navaneethan SD, Craig JC, et al. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database Syst Rev 2014;5:CD007784. Palmer SC, Navaneethan SD, Craig JC, et al. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database Syst Rev 2014;5:CD007784.
12.
Zurück zum Zitat Blood Pressure Lowering Treatment Trialists C, Ninomiya T, Perkovic V, et al. Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials. Bmj. 2013;347:f5680. Blood Pressure Lowering Treatment Trialists C, Ninomiya T, Perkovic V, et al. Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials. Bmj. 2013;347:f5680.
13.
Zurück zum Zitat Holtkamp FA, de Zeeuw D, de Graeff PA, et al. Albuminuria and blood pressure, independent targets for cardioprotective therapy in patients with diabetes and nephropathy: a post hoc analysis of the combined RENAAL and IDNT trials. Eur Heart J 2011;32(12):1493–1499.PubMed Holtkamp FA, de Zeeuw D, de Graeff PA, et al. Albuminuria and blood pressure, independent targets for cardioprotective therapy in patients with diabetes and nephropathy: a post hoc analysis of the combined RENAAL and IDNT trials. Eur Heart J 2011;32(12):1493–1499.PubMed
14.
Zurück zum Zitat Jafar TH, Schmid CH, Landa M, et al. Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. Ann Intern Med. 2001;135(2):73–87.PubMed Jafar TH, Schmid CH, Landa M, et al. Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. Ann Intern Med. 2001;135(2):73–87.PubMed
15.
Zurück zum Zitat Sarnak MJ, Greene T, Wang X, et al. The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study. Ann Intern Med. 2005;142(5):342–351.PubMed Sarnak MJ, Greene T, Wang X, et al. The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study. Ann Intern Med. 2005;142(5):342–351.PubMed
16.
Zurück zum Zitat Shurraw S, Hemmelgarn B, Lin M, et al. Association between glycemic control and adverse outcomes in people with diabetes mellitus and chronic kidney disease: a population-based cohort study. Arch Intern Med. 2011;171(21):1920–1927.PubMed Shurraw S, Hemmelgarn B, Lin M, et al. Association between glycemic control and adverse outcomes in people with diabetes mellitus and chronic kidney disease: a population-based cohort study. Arch Intern Med. 2011;171(21):1920–1927.PubMed
17.
Zurück zum Zitat Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352(9131):837–853. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352(9131):837–853.
18.
Zurück zum Zitat Gooch K, Culleton BF, Manns BJ, et al. NSAID use and progression of chronic kidney disease. Am J Med. 2007;120(3):280 e281–287. Gooch K, Culleton BF, Manns BJ, et al. NSAID use and progression of chronic kidney disease. Am J Med. 2007;120(3):280 e281–287.
19.
Zurück zum Zitat KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl 2013(3):19–62. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl 2013(3):19–62.
20.
Zurück zum Zitat KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int Suppl. 2012;2(5):337–414. KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int Suppl. 2012;2(5):337–414.
21.
Zurück zum Zitat Tuot DS, Powe NR. Chronic kidney disease in primary care: an opportunity for generalists. J Gen Intern Med 2011;26(4):356–358.PubMedPubMedCentral Tuot DS, Powe NR. Chronic kidney disease in primary care: an opportunity for generalists. J Gen Intern Med 2011;26(4):356–358.PubMedPubMedCentral
22.
Zurück zum Zitat Litvin CB, Nietert PJ, Wessell AM, Jenkins RG, Ornstein SM. Recognition and management of CKD in primary care. Am J Kidney Dis 2011;57(4):646–647.PubMedPubMedCentral Litvin CB, Nietert PJ, Wessell AM, Jenkins RG, Ornstein SM. Recognition and management of CKD in primary care. Am J Kidney Dis 2011;57(4):646–647.PubMedPubMedCentral
23.
Zurück zum Zitat Allen AS, Forman JP, Orav EJ, Bates DW, Denker BM, Sequist TD. Primary care management of chronic kidney disease. J Gen Intern Med 2011;26(4):386–392.PubMed Allen AS, Forman JP, Orav EJ, Bates DW, Denker BM, Sequist TD. Primary care management of chronic kidney disease. J Gen Intern Med 2011;26(4):386–392.PubMed
24.
Zurück zum Zitat Israni RK, Shea JA, Joffe MM, Feldman HI. Physician characteristics and knowledge of CKD management. Am J Kidney Dis 2009;54(2):238–247.PubMed Israni RK, Shea JA, Joffe MM, Feldman HI. Physician characteristics and knowledge of CKD management. Am J Kidney Dis 2009;54(2):238–247.PubMed
25.
Zurück zum Zitat Lea JP, McClellan WM, Melcher C, Gladstone E, Hostetter T. CKD risk factors reported by primary care physicians: do guidelines make a difference? Am J Kidney Dis 2006;47(1):72–77.PubMed Lea JP, McClellan WM, Melcher C, Gladstone E, Hostetter T. CKD risk factors reported by primary care physicians: do guidelines make a difference? Am J Kidney Dis 2006;47(1):72–77.PubMed
26.
Zurück zum Zitat Plantinga LC, Tuot DS, Powe NR. Awareness of chronic kidney disease among patients and providers. Adv Chronic Kidney Dis 2010;17(3):225–236.PubMedPubMedCentral Plantinga LC, Tuot DS, Powe NR. Awareness of chronic kidney disease among patients and providers. Adv Chronic Kidney Dis 2010;17(3):225–236.PubMedPubMedCentral
27.
Zurück zum Zitat Tuot DS, Plantinga LC, Hsu CY, Powe NR. Is awareness of chronic kidney disease associated with evidence-based guideline-concordant outcomes? Am J Nephrol 2012;35(2):191–197.PubMedPubMedCentral Tuot DS, Plantinga LC, Hsu CY, Powe NR. Is awareness of chronic kidney disease associated with evidence-based guideline-concordant outcomes? Am J Nephrol 2012;35(2):191–197.PubMedPubMedCentral
28.
Zurück zum Zitat Greer RC, Cooper LA, Crews DC, Powe NR, Boulware LE. Quality of patient-physician discussions about CKD in primary care: a cross-sectional study. Am J Kidney Dis 2011;57(4):583–591.PubMed Greer RC, Cooper LA, Crews DC, Powe NR, Boulware LE. Quality of patient-physician discussions about CKD in primary care: a cross-sectional study. Am J Kidney Dis 2011;57(4):583–591.PubMed
29.
Zurück zum Zitat Rettig RA, Norris K, Nissenson AR. Chronic kidney disease in the United States: a public policy imperative. Clin J Am Soc Nephrol 2008;3(6):1902–1910.PubMed Rettig RA, Norris K, Nissenson AR. Chronic kidney disease in the United States: a public policy imperative. Clin J Am Soc Nephrol 2008;3(6):1902–1910.PubMed
30.
Zurück zum Zitat Diamantidis CJ, Powe NR, Jaar BG, Greer RC, Troll MU, Boulware LE. Primary care-specialist collaboration in the care of patients with chronic kidney disease. Clin J Am Soc Nephrol 2011;6(2):334–343.PubMedPubMedCentral Diamantidis CJ, Powe NR, Jaar BG, Greer RC, Troll MU, Boulware LE. Primary care-specialist collaboration in the care of patients with chronic kidney disease. Clin J Am Soc Nephrol 2011;6(2):334–343.PubMedPubMedCentral
31.
Zurück zum Zitat Haley WE, Beckrich AL, Sayre J, et al. Improving care coordination between nephrology and primary care: a quality improvement initiative using the renal physicians association toolkit. Am J Kidney Dis 2015;65(1):67–79.PubMed Haley WE, Beckrich AL, Sayre J, et al. Improving care coordination between nephrology and primary care: a quality improvement initiative using the renal physicians association toolkit. Am J Kidney Dis 2015;65(1):67–79.PubMed
32.
Zurück zum Zitat Fink HA, Ishani A, Taylor BC, et al. Screening for, monitoring, and treatment of chronic kidney disease stages 1 to 3: a systematic review for the U.S. Preventive Services Task Force and for an American College of Physicians Clinical Practice Guideline. Ann Intern Med. 2012;156(8):570–581.PubMed Fink HA, Ishani A, Taylor BC, et al. Screening for, monitoring, and treatment of chronic kidney disease stages 1 to 3: a systematic review for the U.S. Preventive Services Task Force and for an American College of Physicians Clinical Practice Guideline. Ann Intern Med. 2012;156(8):570–581.PubMed
33.
Zurück zum Zitat Berns JS, Ellison DH, Linas SL, Rosner MH. Training the next generation’s nephrology workforce. Clin J Am Soc Nephrol. Sep 5 2014;9(9):1639–1644. Berns JS, Ellison DH, Linas SL, Rosner MH. Training the next generation’s nephrology workforce. Clin J Am Soc Nephrol. Sep 5 2014;9(9):1639–1644.
34.
Zurück zum Zitat Brosius FC, 3rd, Hostetter TH, Kelepouris E, et al. Detection of chronic kidney disease in patients with or at increased risk of cardiovascular disease: a science advisory from the American Heart Association Kidney and Cardiovascular Disease Council; the Councils on High Blood Pressure Research, Cardiovascular Disease in the Young, and Epidemiology and Prevention; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: Developed in Collaboration With the National Kidney Foundation. Hypertension. 2006;48(4):751–755.PubMed Brosius FC, 3rd, Hostetter TH, Kelepouris E, et al. Detection of chronic kidney disease in patients with or at increased risk of cardiovascular disease: a science advisory from the American Heart Association Kidney and Cardiovascular Disease Council; the Councils on High Blood Pressure Research, Cardiovascular Disease in the Young, and Epidemiology and Prevention; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: Developed in Collaboration With the National Kidney Foundation. Hypertension. 2006;48(4):751–755.PubMed
35.
Zurück zum Zitat American Diabetes A. 11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes-2019. Diabetes Care 2019;42(Suppl 1):S124-S138. American Diabetes A. 11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes-2019. Diabetes Care 2019;42(Suppl 1):S124-S138.
36.
Zurück zum Zitat Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42(6):1206–1252.PubMed Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42(6):1206–1252.PubMed
38.
Zurück zum Zitat Litvin CB, Ornstein SM. Quality indicators for primary care: an example for chronic kidney disease. J Ambulatory Care Manag 2014;37(2):171–178. Litvin CB, Ornstein SM. Quality indicators for primary care: an example for chronic kidney disease. J Ambulatory Care Manag 2014;37(2):171–178.
39.
Zurück zum Zitat Nietert PJ, Jenkins RG, Nemeth LS, Ornstein SM. An application of a modified constrained randomization process to a practice-based cluster randomized trial to improve colorectal cancer screening. Contemp Clin Trials 2009;30(2):129–132.PubMed Nietert PJ, Jenkins RG, Nemeth LS, Ornstein SM. An application of a modified constrained randomization process to a practice-based cluster randomized trial to improve colorectal cancer screening. Contemp Clin Trials 2009;30(2):129–132.PubMed
40.
Zurück zum Zitat Weissman NW, Allison JJ, Kiefe CI, et al. Achievable benchmarks of care: the ABCs of benchmarking. J Eval Clin Pract 1999;5(3):269–281.PubMed Weissman NW, Allison JJ, Kiefe CI, et al. Achievable benchmarks of care: the ABCs of benchmarking. J Eval Clin Pract 1999;5(3):269–281.PubMed
41.
Zurück zum Zitat Nemeth LS. Synthesizing Lessons Learned Within a Practice-Based Research Network (PPRNet). 26th Annual Conference of the Southern Nursing Research Society; Feb 25, 2012, 2012; New Orleans, LA. Nemeth LS. Synthesizing Lessons Learned Within a Practice-Based Research Network (PPRNet). 26th Annual Conference of the Southern Nursing Research Society; Feb 25, 2012, 2012; New Orleans, LA.
42.
Zurück zum Zitat Nemeth LS. Making Sense of Electronic Medical Record Adoption as Complex Interventions in Primary Health Care: Synthesizing Lessons Learned With Complex Interventions in a Research Network (PPRNet). Innovations for Health System Improvement: Balancing Costs, Quality and Equity; Annual CAHSPR Conference 2012; 2012; Montreal, Quebec, Canada. Nemeth LS. Making Sense of Electronic Medical Record Adoption as Complex Interventions in Primary Health Care: Synthesizing Lessons Learned With Complex Interventions in a Research Network (PPRNet). Innovations for Health System Improvement: Balancing Costs, Quality and Equity; Annual CAHSPR Conference 2012; 2012; Montreal, Quebec, Canada.
43.
Zurück zum Zitat Nemeth LS, Nietert PJ, Ornstein SM. High performance in screening for colorectal cancer: a Practice Partner Research Network (PPRNet) case study. J Am Board Fam Med 2009;22(2):141–146.PubMedPubMedCentral Nemeth LS, Nietert PJ, Ornstein SM. High performance in screening for colorectal cancer: a Practice Partner Research Network (PPRNet) case study. J Am Board Fam Med 2009;22(2):141–146.PubMedPubMedCentral
44.
Zurück zum Zitat Nemeth LS, Wessell AM, Jenkins RG, Nietert PJ, Liszka HA, Ornstein SM. Strategies to accelerate translation of research into primary care within practices using electronic medical records. J Nurs Care Qual 2007;22(4):343–349.PubMed Nemeth LS, Wessell AM, Jenkins RG, Nietert PJ, Liszka HA, Ornstein SM. Strategies to accelerate translation of research into primary care within practices using electronic medical records. J Nurs Care Qual 2007;22(4):343–349.PubMed
45.
Zurück zum Zitat Nemeth LS, Ornstein SM, Jenkins RG, Wessell AM, Nietert PJ. Implementing and evaluating electronic standing orders in primary care practice: a PPRNet study. J Am Board Fam Med 2012;25(5):594–604.PubMed Nemeth LS, Ornstein SM, Jenkins RG, Wessell AM, Nietert PJ. Implementing and evaluating electronic standing orders in primary care practice: a PPRNet study. J Am Board Fam Med 2012;25(5):594–604.PubMed
46.
Zurück zum Zitat Greer RC, Powe NR, Jaar BG, Troll MU, Boulware LE. Effect of primary care physicians’ use of estimated glomerular filtration rate on the timing of their subspecialty referral decisions. BMC Nephrol 2011;12:1.PubMedPubMedCentral Greer RC, Powe NR, Jaar BG, Troll MU, Boulware LE. Effect of primary care physicians’ use of estimated glomerular filtration rate on the timing of their subspecialty referral decisions. BMC Nephrol 2011;12:1.PubMedPubMedCentral
47.
Zurück zum Zitat Tsang JY, Blakeman T, Hegarty J, Humphreys J, Harvey G. Understanding the implementation of interventions to improve the management of chronic kidney disease in primary care: a rapid realist review. Implement Sci. 2016;11:47.PubMedPubMedCentral Tsang JY, Blakeman T, Hegarty J, Humphreys J, Harvey G. Understanding the implementation of interventions to improve the management of chronic kidney disease in primary care: a rapid realist review. Implement Sci. 2016;11:47.PubMedPubMedCentral
48.
Zurück zum Zitat Litvin CB, Hyer JM, Ornstein SM. Use of Clinical Decision Support to Improve Primary Care Identification and Management of Chronic Kidney Disease (CKD). J Am Board Fam Med 2016;29(5):604–612.PubMed Litvin CB, Hyer JM, Ornstein SM. Use of Clinical Decision Support to Improve Primary Care Identification and Management of Chronic Kidney Disease (CKD). J Am Board Fam Med 2016;29(5):604–612.PubMed
49.
Zurück zum Zitat Carroll JK, Pulver G, Dickinson LM, et al. Effect of 2 Clinical Decision Support Strategies on Chronic Kidney Disease Outcomes in Primary Care: A Cluster Randomized Trial. JAMA Netw Open. 2018;1(6):e183377.PubMedPubMedCentral Carroll JK, Pulver G, Dickinson LM, et al. Effect of 2 Clinical Decision Support Strategies on Chronic Kidney Disease Outcomes in Primary Care: A Cluster Randomized Trial. JAMA Netw Open. 2018;1(6):e183377.PubMedPubMedCentral
50.
Zurück zum Zitat Komenda P, Ferguson TW, Macdonald K, et al. Cost-effectiveness of primary screening for CKD: a systematic review. Am J Kidney Dis 2014;63(5):789–797.PubMed Komenda P, Ferguson TW, Macdonald K, et al. Cost-effectiveness of primary screening for CKD: a systematic review. Am J Kidney Dis 2014;63(5):789–797.PubMed
51.
Zurück zum Zitat Hoerger TJ, Wittenborn JS, Segel JE, et al. A health policy model of CKD: 1. Model construction, assumptions, and validation of health consequences. Am J Kidney Dis 2010;55(3):452–462.PubMed Hoerger TJ, Wittenborn JS, Segel JE, et al. A health policy model of CKD: 1. Model construction, assumptions, and validation of health consequences. Am J Kidney Dis 2010;55(3):452–462.PubMed
Metadaten
Titel
Translating CKD Research into Primary Care Practice: a Group-Randomized Study
verfasst von
Cara B. Litvin, MD, MS
Paul J. Nietert, PhD
Ruth G. Jenkins, PhD
Andrea M. Wessell, PharmD
Lynne S. Nemeth, PhD, RN
Steven M. Ornstein, MD
Publikationsdatum
10.12.2019
Verlag
Springer International Publishing
Erschienen in
Journal of General Internal Medicine / Ausgabe 5/2020
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-019-05353-4

Weitere Artikel der Ausgabe 5/2020

Journal of General Internal Medicine 5/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.